mBC, also known as "advanced breast cancer," is cancer that starts in the breast tissue and then spreads to other parts of the body.
There are 4 main breast cancer subtypes based on the presence or absence of hormone receptors (HRs) and human epidermal growth factor receptor 2 (HER2/neu).*
*Based on data from cases in 2012-2016.
Triple-negative breast cancer (TNBC) is a subtype of breast cancer that accounts for about 10% of all breast cancers. TNBC does not have estrogen or progesterone receptors (hormone-negative), is HER2/neu-negative, and typically spreads and grows faster than other breast cancers.
†Based on data from cases in 2012-2016.
Let your health care team know when you experience side effects. Keep track of your side effects and what affects them. This information may be helpful to your health care team when making decisions regarding your treatment.
For more information about the disease, visit this page.
HALAVEN is a prescription medicine used to treat adults with breast cancer that has spread to other parts of the body, and who have already received other types of anticancer medicines after the cancer has spread.
HALAVEN can cause serious side effects, including
Before you receive HALAVEN, tell your health care provider about all of your medical conditions, including if you
Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the possible side effects of HALAVEN?
HALAVEN can cause changes in your heartbeat (called QT prolongation). This can cause irregular heartbeats. Your health care provider may do heart monitoring (electrocardiogram or ECG) or blood tests during your treatment with HALAVEN to check for heart problems.
The most common side effects of HALAVEN in adults with breast cancer include low white blood cell count (neutropenia), low red blood cell count (anemia), weakness or tiredness, hair loss (alopecia), nausea, and constipation.
Your health care provider will do blood tests before and during treatment while you are taking HALAVEN.
For more information about HALAVEN, please see full Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.